Abstract
Over the last decade, the neuroinflammatory hypothesis of neurodegeneration has become well established. Our increased scientific understanding of the cascade(s) of events involved in chronic, slowly progressing neurodegenerative diseases has established the foundations for the first mechanistic drug discovery programs for the pharmacological treatment of these devastating diseases. An exciting feature of the neuroinflammatory hypothesis is that a target cell, microglia, has been identified for pharmacological approaches to halting or preventing slowly progressing neurodegenerative diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McGeer, P. L., Itagaki, S., Boyes, B. E., and McGeer, E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38, 1285–1291.
McGeer, P. L., Akiyama, H., Itagaki, S., and McGeer, E. G. (1989) Immune system response in Alzheimer’s disease. Can. J. Neurol. Sci. 16, 516–527.
McGeer, P. L., Walker, D. G., Akiyama, H., Kawamata, T., Guan, A. L., Parker, C. J., et al. (1991) Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain. Brain Res. 544, 315–319.
Itagaki, S., McGeer, P. L., and Akiyama, H. (1988) Presence of T-cytotoxic suppressor and leukocyte common antigen positive cells in Alzheimer’s disease brain tissue. Neuro-sci. Lett. 91, 259–264.
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., and Selkoe, D. (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24, 173–182.
Griffin, W. S. T., Stanley, L. C., Ling, C., White, L., McLeod, V., Perrot, L. J., et al. (1989) Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 7611–7615.
Griffin, W. S. T., Sheng, J. G., Roberts, G. W., and Mrak, R. E. (1995) Interleukin-1 expression in different plaque types in Alzheimer’ s disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54, 276–281.
Perlmutter, L. S., Barron, E., and Chui, H. C. (1990) Morphologic association between microglia and senile plaque amyloid in Alzheimer’s disease. Neurosci. Lett. 119, 32–36.
Perlmutter, L. S., Scott, S. A., Barrón, E., and Chui, H. C. (1992) MHC class II-positive microglia in human brain: association with Alzheimer lesions. J. Neurosci. Res. 33, 549–558.
Rozemuller, J. M., Eikelenboom, P., Pals, S. T., and Stam, F. C. (1989) Microglial cells around amyloid plaques in Alzheimer’s disease express leukocyte adhesion molecules of the LFA-1 family. Neurosci. Lett. 101, 288–292.
Rozemuller, J. M., Van der Valk, P., and Eikelenboom, P. (1992) Activated microglia and cerebral amyloid deposits in Alzheimer’s disease. Res. Immunol. 143, 646–649.
Tooyama, I., Kimura, H., Akiyama, H., and McGeer, P. L. (1990) Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer’s disease. Brain Res. 523, 273–280.
Masliah, E., Mallory, M., Hansen, L., Alford, M., Albright, T., Terry, R., Shapiro, P., et al. (1991) Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer’s disease. Acta Neuropathol. (Berl.) 83, 12–20.
Cras, P., Kawai, M., Siedlak, S., Mulvihill, P., Gambetti, P., Lowery, D., et al. (1990) Neuronal and microglial involvement in (3-amyloid protein deposition in Alzheimer’s disease. Am. J. Pathol. 137, 241–246.
Cras, P., Kawai, M., Siedlak, S., and Perry, G. (1991) Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease. Brain Res. 558, 312–314.
Johnson, S. A., Lampert-Etchells, M., Pasinetti, G. M., Rozovsky, I., Finch, C. E., et al. (1992) Complement mRNA in the mammalian brain: responses to Alzheimer’s disease and experimental brain lesioning. Neurobiol. Aging 13, 641–648.
Akiyama, H. and McGeer, P. L. (1990) Brain microglia constituitively express (3–2 integrins. J. Neuroimmunol. 30, 81–93.
Akiyama, H., Kawamata, T., Dedhar, S., and McGeer, P. L. (1991) Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue. J. Neuroimmunol. 32, 19–28.
Akiyama, H., Yamada, T., Kawamata, T., and McGeer, P. L. (1991) Association of amyloid P component with complement proteins in neurologically diseased brain tissue. Brain Res. 548, 349–352.
Akiyama, H., Ikeda, K., Kondo, H., Kato, M., and McGeer, P. L. (1993) Microglia express the type 2 plasminogen activator inhibitor in the brain of control subjects and patients with Alzheimer’s disease. Neurosci. Lett. 164, 233–235.
Akiyama, H., Nishimura, T., Kondo, H., Ikeda, K., Hayashi, Y., and McGeer, P. L. (1994) Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains with Alzheimer’ s disease and amyotrophic lateral sclerosis. Brain Res. 639, 171–174.
Mrak, R. E., Sheng, J. G., and Griffin, W. S. T. (1995) Glial cytokines in Alzheimer’s disease: review and pathogenic implications. Hum. Pathol. 26, 816–823.
Yamada, T., Kawamata, T., Walker, D. G., and McGeer, P. L. (1992) Vimentin immunoreactivity in normal and pathological human brain tissue. Acta Neuropathol. (Berl.) 84, 157–162.
Yamada, T., Miyazaki, K., Koshikawa, N., Takahashi, M., Akatsu, H., and Yamamoto, T. (1995) Selective localization of gelatinase A, an enzyme degrading (3-amyloid protein, in white matter microglia and in Schwann cells. Acta Neuropathol. (Berl.) 89, 199–203.
Yamada, T., Yoshiyama, Y., Sato, H., Seiki, M., Shinagawa, A., and Takahashi, M. (1995) White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues. Acta Neuropathol. (Berl.) 90, 421–424.
Akiyama, H., Arai, T., Kondo, H., Tanno, E., Haga, C., and Ikeda, K. (2000) Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. 14, S47 - S53.
Arends, Y. M., Duyckaerts, C., Rozemuller, J. M., Eikelenboom, P., and Hauw, J. J. (2000) Microglia, amyloid and dementia in Alzheimer disease—a correlative study. Neurobiol. Aging 21, 39–47.
McGeer, P. L., McGeer, E. G., and Yasojima, K. (2000) Alzheimer disease and neuro-inflammation. J. Neural Transm. 59, 53–57.
Sheffield, L. G., Marquis, J. G., and Berman, N. J. (2000) Regional distribution of cortical microglia parallels that of neurofibrillary tangles in Alzheimer’s disease. Neurosci. Lett. 285, 165–168.
Togo, T., Akiyama, H., Kondo, H., Ikeda, K., Kato, M., Iseki, E., and Kosaka, K. (2000) Expression of CD40 in the brain of Alzheimer’s disease and other neurological diseases. Brain Res. 885, 117–121.
Wegiel, J., Wang, K. C., Tarnawski, M., and Lach, B. (2000) Microglial cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plaque degradation. Acta Neuropathol. 100, 356–364.
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., et al. (2001) In-vivo measurement of activated microglia in dementia. Lancet 358, 461–467.
Park, C. H., Carboni, E., Wood, P. L., and Gee, K. W. (1996) Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line. Glia 16, 65–70.
Stephenson, D. T., Schober, D. A., Smalstig, E. B., Mincy, R. E., Gehlert, D. R., and Clemens, J. A. (1995) Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J. Neurosci. 15, 5263–5274.
Prosperi, C., Scali, C., Pepeu, G., and Casamenti, F. (2001) NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain. Jpn. J. Pharmacol. 86 (2), 230–235.
Rossner, S., Härtig, W., Schliebs, R., Brückner, G., Brauer, K., Perez-Polo, J. R., et al. (1995) IgG-saporin immunotoxin-induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei. J. Neurosci. Res. 41, 335–346.
Kim, W. G., Mohney, R. P., Wilson, B., Jeohn, G. H., Liu, B., and Hong, J. S. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309–6316.
Coffey, P. J., Perry, V. H., Allen, Y., Sinden, J., and Rawlins, J. N. P. (1988) Ibotenic acid induced demyelination in the central nervous system: a consequence of a local inflammatory response. Neurosci. Lett. 84, 178–184.
Coffey, P. J., Perry, V. H., and Rawlins, J. N. P. (1990) An investigation into the early stages of the inflammatory response following ibotenic acid-induced neuronal degeneration. Neuroscience 35, 121–132.
Bernal, F., Saura, J., Ojuel, J., and Mahy, N. (2000) Differential vulnerability of hippocampus, basal ganglia, and prefrontal cortex to long-term NMDA excitotoxicity. Exp. Neurol. 161, 686–695.
Lu, X. R. and Ong, W.Y. (2001) Heme oxgenase-1 is expressed in viable astrocytes and mircoglia but in degenerating pyramidal neurons in the kainate-lesioned rat hippocampus. Exp. Brain Res. 137, 424–431.
Finsen, B. R., Jorgensen, M. B., Diemer, N. H., and Zimmer, J. (1993) Microglial MHC antigen expression after ischemic and kainic acid lesions of the adult rat hippocampus. Glia 7, 41–49.
Andersson, P.-B., Perry, V. H., and Gordon, S. (1991) The CNS acute inflammatory response to excitotoxic neuronal cell death. Immunol. Lett. 30, 177–182.
Jorgensen, M. B., Finsen, B. R., Jensen, M. B., Castellano, B., Diemer, N. H., and Zimmer, J. (1993) Microglial and astroglial reactions to ischemic kainic acid-induced lesions of the adult rat hippocampus. Exp. Neurol. 120, 70–88.
Wright, J. L. and Merchant, R. E. (1992) Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-a in the rat. Acta Neuropathol. (Berl.) 85, 93–100.
Benzing, W. C., Wujek, J. R., Ward, E. K., Shaffer, D., Ashe, K. H., Younkin, S. G., et al. (1999) Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol. Aging 20, 581–589.
Mehlhorn, G., Hollborn, M., and Schliebs, R. (2000) Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int. J. Dev. Neurosci. 18, 423–431.
Apelt, J. and Schliebs, R. (2001) 3-Amyloid-induced glial expression of both pro-and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res. 894, 21–30.
Bornemann, K. D., Wiederhold, K. H., Pauli, C., Ermini, F., Stalder, M., Schnell, L., et al. (2001) A(3-Induce inflammatory processes in microglia cells of APP23 transgenic mice. Am. J. Pathol. 158, 63–73.
Murphy, G. M., Zhao, F. F., Yang, L., and Cordell, B. (2000) Expression of macrophage colony-stimulating factor receptor is increased in the A beta PPV717F transgenic mouse model of Alzheimer’s disease. Am. J. Pathol. 157, 895–904.
Matsuoka, Y., Picciano, M., Malester, B., LaFrancois, J., Zehr, C., Daeschner, J. M., et al. (2001) Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease. Am. J. Pathol. 158, 1345–1354.
McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I., and McGeer, E. G. (1993) Microglia in degenerative neurological disease. Glia 7, 84–92.
Knott, C., Stern, G., and Wilkin, G. P. (2000) Inflammatory regulators in Parkinson’s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and-2. [review]. Mol. Cell. Neurosci. 16, 724–739.
Mirza, B., Hadberg, H., Thomsen, P., and Moos, T. (2000) The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson’s disease. Neuroscience 95 (2), 425–432.
Mackenzie, I. A. (2000) Activated microglia in dementia with Lewy bodies. Neurology 55, 132–134.
Jellinger, K. A. (2000) Cell death mechanisms in Parkinson’s disease. [review]. J. Neural Transm. 107, 1–29.
Mackenzie, I. A. (2000) Activated microglia in dementia with Lewy bodies. Neurology 55, 132–134.
Lawson, L. J., Perry, V. H., Dri, P., and Gordon, S. (1990) Heterogeneity in distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151–170.
Akiyama, H. and McGeer, P. L, (1989) Microglial response to 6-hydroxydopamine-induced substantia nigra lesions. Brain Res. 489, 247–253.
Haruhiko, A. and McGeer, P. L. (1989) Microglial response to 6-hydroxydopamine-induced substantia nigra lesions. Brain Res. 489, 247–253.
Kim, W. G., Mohney, R. P., Wilson, B., Jeohn, G. H., Liu, B., and Hong, J. S. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309–6316.
Herrera, A. J., Castano, A., Venero, J. L., Cano, J., and Machado, A. (2000) The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiology 7, 429–447.
Grunblatt, E., Mandel, S., and Youdim, M. H. (2000) MPTP and 6-hydroxydopamineinduced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies. J. Neurol. 247, 95–102.
Li, H., Newcombe, J., Groome, P., and Cuzner, M. L. (1993) Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 19, 214–223.
Bö, L., Mork, S., Kong, P. A., Nyland, H., Pardo, C. A., and Trapp, B. D. (1994) Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J. Neuroimmunol. 51, 135–146.
Brosnan, C. F., Cannella, B., Battistini, L., and Raine, C. S. (1995) Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 45 (Suppl. 6), S16 - S21.
Boyle, E. A. and McGeer, P. L. (1990) Cellular immune response in multiple sclerosis plaques. Am. J. Pathol. 137, 575–584.
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F. G. et al. (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosisquantitative in vivo imaging of microglia as a measure of disease activity. Brain 123, 2321–2337.
Bitsch, A., Kuhlmann, T., Da Costa, C., Bunkowski, S., Polak, T., and Bruck, W. (2000) Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology. Glia 29, 366–375.
Bever, C. T. Jr. and Garver, D. W. (1995) Increased cathepsin B activity in multiple sclerosis brain. J. Neurol. Sci. 131, 71–73.
Matsumoto, Y., Ohmori, K., and Fujiwara, M. (1992) Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J. Neuroimmunol. 37, 23–33.
Bauer, J., Sminia, T., Wouterlood, F. G., and Dijkstra, C. D. (1994) Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J. Neurosci. Res. 38, 365–375.
Renno, T., Krakowski, M., Piccirillo, C., Lin, J., and Owens, T. (1995) TNF-a expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: regulation by Thl cytokines. J. Immunol. 154, 944–953.
Bauer, J., Berkenbosch, F., VanDam, A.-M., and Dijkstra, C. D. (1993) Demonstration of interleukin-lß in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J. Neuroimmunol. 48, 13–22.
Linington, C., Lassmann, H., Morgan, B. P., and Compston, D. A. S. (1989) Immunohistochemical localization of terminal complement component C9 in experimental allergic encephalomelitis. Acta Neuropathol. 79, 78–85.
Banati, R. B., Gehrmann, J., Lannes-Vieira, J., Wekerle, H., and Kreutzberg, G. W. (1995) Inflammatory reaction in experimental autoimmune encephalomyelitis (EAE) is accompanied by a microglial expression of the [3A4-amyloid precursor protein (APP). Glia 14, 209–215.
Sapp, E., Kegel, K. B., Aronin, N., Hashikawa, T., Uchiyama, Y., Tohyama, K. P. G. et al. (2001) Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 60, 161–172.
Töpper, R., Gehrmann, J., Schwarz, M., Block, F., Noth, J., and Kreutzberg, G. W. (1993) Remote microglial activation in the quinolinic acid model of Huntington’s disease. Exp. Neurol. 123, 271–283.
Bresjanac, M. and Antauer, G. (2000) Reactive astrocytes of the quinolinc acid-lesioned rat striatum express GFR alpha 1 as well as GDNF in vivo. Exp. Neurol. 164, 53–59.
Ishizawa, K. and Dickson, D. W. (2001) Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J. Neuropathol. Exp. Neurol. 60, 647–657.
Aoki, T., Kobayashi, K., and Isaki, K. (1999) Microglial and astrocytic change in brains of Creutzfeldt-Jakob disease: an immunocytochemical and quantitative study. Clin. Neuropathol. 18, 51–60.
Muhleisen, H., Gehrmann, J., and Meyermann, R. (1995) Reactive microglia in Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol. 21, 505–517.
Rezaie, P. and Lantos, P. L. (2001) Microglia and the pathogenesis of spongiform encephalopathies. [review]. Brain Res. Rev. 35, 55–72.
Bugiani, O., Giaccone, G., Piccardo, P., Morbin, M., Tagliavini, F., and Ghetti, B. (2000) Neuropathology of Gerstmann-Straussler-Scheinker disease. Microscopy 50, 10–15.
Brown, D. R., Schmidt, B., and Kretzschmar, H. A. (1996) Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380, 345–347.
Glass, J. D. and Wesselingh, S. L. (2001) Microglia in HIV-associated neurological diseases. Microsc. Res. Tech. 54, 95–105.
Kure, K., Weidenheim, K. M., Lyman, W. D., and Dickson, D. W. (1990) Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol. (Berl.) 80, 393–400.
Cagnin, A., Myers, R., Gunn, R. N., Lawrence, A. D., Stevens, T., Kreutzberg, G. W., et al. (2001) In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 124, 2014–2027.
Lynch, W. P., Czub, S., McAtee, F. J., Hayes, S. F., and Portis, J. L. (1991) Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron 7, 365–379.
Lynch, W. P., Robertson, S. J., and Portis, J. L. (1995) Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia. J. Virol. 69, 1408–1419.
Gillespie, J. S., Cavanagh, H. M. A., Behan, W. M. H., Morrison, L. J. A., McGarry, F., and Behan, P. O. (1993) Increased transcription of interleukin-6 in the brains of mice with chronic enterovirus infection. J. Gen. Virol. 74, 741–743.
Penfold, P. L., Madigan, M. C., Gillies, M. C., and Provis, J. M. (2001) Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res. 20, 385–414.
Rungger-Brandle, E., Dosso, A. A., and Leuenberger, P. M. (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 41, 1971–1980.
Zeng, X. X., Ng, Y. K., and Ling, E. A. (2000) Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis. Neurosci. 17, 463–471.
Shin, D. H., Lee, H. Y., Lee, H. W., Lee, K. H., Lim, H. S., Jeon, G. S., et al. (2000) Activation of microglia in kainic acid induced rat retinal apoptosis. Neurosci. Lett. 292, 159–162.
Neufeld, A. H. (1999) Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch. Ophthalmol. 117, 1050–1056.
Wang, X., Tay, S. W., and Ng, Y. K. (2000) An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Exp. Brain Res. 132, 476–484.
Beschorner, R., Engel, S., Mittelbronn, M., Adjodah, D., Dietz, K., Schluesener, H. J., et al. (2000) Differential regulation of the monocytic calcium-binding peptides macrophage-inhibiting factor related protein-8 (MRP8/S100A8) and allograft inflammatory factor-1 (AIF-1) following human traumatic brain injury. Acta Neuropathol. 100, 627–634.
Beschorner, R., Schluesener, H. J., Nguyen, T. D., Magdolen, V., Luther, T., Pedal, I., et al. (2000) Lesion-associated accumulation of uPAR/CD87-expressing infiltrating granulocytes, activated microglial cells/macrophages and upregulation by endothelial cells following TBI and FCI in humans. Acta Neuropathol. 100, 627–634.
Engel, S., Schluesener, H., Mittelbronn, M., Seid, K., Adjodah, D., Wehner, H. D., et al. (2000) Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol. 100, 313–322.
Beschorner, R., Adjodah, D., Schwab, J. M., Mittelbronn, M., Pedal, I., Mattern, R., et al. (2000) Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol. 100, 377–384.
Aihara, N., Hall, J. J., Pitts, L. H., Fukuda, K., and Noble, L. J. (1995) Altered immunoexpression of microglia and macrophages after mild head injury. J. Neurotrauma 12, 53–64.
Griffin, W. S., Sheng, J. G., Gentleman, S. M., Graham, D. I., Mrak, R. E., and Riberts, G. W. (1994) Microglial interleukin-la expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci. Lett. 176, 133–136.
Takeuchi, A., Miyaishi, O., Kiuchi, K., and Isobe, K. (2001) Macrophage colony-stimulating factor is expressed in neuron and microglia after focal brain injury. J. Neurosci. Res. 65, 38–44.
Mautes, A. E. M. and Noble, L. J. (2000) Co-induction of HSP70 and heure oxygenase-1 in macrophages and glia after spinal cord contusion in the rat. Brain Res. 883, 233–237.
Schwab, J. M., Brechtel, K., Nguyen, T. D., and Schluesener, H. J. (2000) Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury. J. Neuroimmunol. 111, 122–130.
Dijkstra, S., Geisert, E. E., Gispen, W. H., Bar, P. R., and Joosten, E. J. (2000) Up-regulation of CD81 (target of the antiproliferative antibody; TAPA) by reactive microglia and astrocytes after spinal cord injury in the rat. J. Comp. Neurol. 428, 266–277.
Lee, Y. L., Shih, K., Bao, P., Ghirnikar, R. S., and Eng, L. F. (2000) Cytokine chemokine expression in contused rat spinal cord. Neurochem. Int. 36, 417–425.
Saito, N., Yamamoto, T., Watanabe, T., Abe, Y., and Kumagai, T. (2000) Implications of p53 protein expression in experimental spinal cord injury. J. Neurotrauma 17, 173–182.
Otto, V. I., Stahel, P. F., Rancan, M., Kariya, K., Shohami, E., Yatsiv, I., et al. (2001) Regulation of chemokines and chemokine receptors after experimental closed head injury. Neuroreport 12, 2059–2064.
Beer, R., Franz, G., Srinivasan, A., Hayes, R. L., Pike, B. R., Newcomb, J. K., et al. (2000) Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury. J. Neurochem. 75, 1264–1273.
Beer, R., Franz, G., Schopf, M., Reindl, M., Zelger, B., Schmutzhard, E., et al. (2000) Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J. Cereb. Blood Flow Metab. 20, 669–677.
Sitte, H. H., Wanschitz, J., Budka, H., and Berger, M. L. (2001) Autoradiography with [3H]PK11195 of spinal tract degeneration in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.) 101, 75–78.
Almer, G., Vukosavic, S., Romero, N., and Przedborski, S. (1999) Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 72, 2415–2425.
Nomura, H., Furuta, A., Suzuki, S. O., and Iwaki, T. (2001) Dorsal horn lesion resulting from spinal root avulsion leads to the accumulation of stress-responsive proteins. Brain Res. 893, 84–94.
Fu, K. Y., Light, A. R., and Maixner, W. (2000) Relationship between nociceptor activity, peripheral edema, spinal microglial activation and long-term hyperalgesia induced by formalin. Neuroscience 101, 1127–1135.
Herzberg. U. and Sagen, J. (2001) Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J. Neuroimmunol. 116, 29–39.
Fu, K. Y., Light, A. R., and Maixner, W. (2000) Relationship between nociceptor activity, peripheral edema, spinal microglial activation and long-term hyperalgesia induced by formalin. Neuroscience 101, 1127–1135.
Winkelstein, B. A., Rutkowski, M. D., Sweitzer, S. M., Pahl, J. L., and DeLeo, J. A. (2001) Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses. J. Comp. Neurol. 439, 127–139.
Colbum, R. W., Rickman, A. J., and DeLeo, J. A. (1999) The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp. Neurol. 157, 289–304.
Stuesse, S. L., Cruce, W. R., Lovell, J. A., McBurney, D. L., and Crisp, T. (2000) Micro-glial proliferation in the spinal cord of aged rats with a sciatic nerve injury. Neurosci. Lett. 287, 121–124.
McGeer, P. L. and McGeer, E. G. (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21, 195–218.
Wright, J. L. and Merchant, R. E. (1992) Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-a in the rat. Acta Neuropathol. (Berl.) 85, 93–100.
Simmons, R. D. and Willenborg, D. O. (1990) Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100, 37–42.
Rothwell, N. J. and Strijbos, P. J. L. M. (1995) Cytokines in neurodegeneration and repair. Int. J. Dev. Neurosci. 13, 179–185.
Murphy, G. M. Jr., Jia, X.-C., Song, Y., Ong, E., Shrivastava, R., Bocchini, V., et al. (1995) Macrophage inflammatory protein 1-a mRNA expression in an immortalized micro-glial cell line and cortical astrocyte cultures. J. Neurosci. Res. 40, 755–763.
Ringheim, G. E. (1995) Mitogenic effects of interleukin-5 on microglia. Neurosci. Lett. 201, 131–134.
Atanassov, C. L., Muller, C. D., Dumont, S., Rebel, G., Poindron, P., and Seiler, N. (1995) Effect of ammonia on endocytosis and cytokine production by immortalized human micro-glia and astroglia cells. Neurochem. Int. 27, 417–424.
Sebire, G., Hery, C., Peudenier, S., and Tardieu, M. (1993) Adhesion proteins on human microglial cells and modulation of their expression by IL 1-alpha and TNF-alpha. Res. Virol. 144, 47–52.
Cannella, B. and Raine, C. S. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37, 424–435.
Ryan, R., Sloane, B. F., Sameni, M., and Wood, P. L. (1995) Microglial cathepsin B: an immunological examination of cellular and secreted species. J. Neurochem. 65, 1035–1045.
Banati, R. B., Rothe, G., Valet, G., and Kreutzberg, G. W. (1993) Detection of lysosomal cysteine proteinases in microglia: flow cytometric measurement and histochemcial localization of cathepsin B and L. Glia 7, 183–191.
Kingham, P. J. and Pocock, J. M. (2001) Microglial secreted cathepsin B induces neuronal apoptosis. J. Neurochem. 76, 1475–1484.
Gresser, O., Weber, E., Hellwig, A., Riese, S., Regnier-Vigouroux, A. (2001) Immunocompetent astrocytes and microglia display major differences in the processing of the invariant chain and in the expression of active cathepsin L and cathepsin S. Eur. J. Immunol. 31, 1813–1824.
Yoshiyama, Y., Arai, K., Oki, T., and Hattori, T. (2000) Expression of invariant chain and pro-cathepsin L in Alzheimer’s brain. Neurosci. Lett. 290, 125–128.
Liuzzo, J. P., Petanceska, S. S., and Devi, L. A. (1999) Neurotrophic factors regulate cathepsin S in macrophages and microglia: a role in the degradation of myelin basic protein and amyloid beta peptide. Mol. Med. 5, 334–343.
Cataldo, A. M. and Nixon, R. A. (1990) Increased cathepsin B activity in multiple sclerosis brain. Proc. Natl. Acad. Sci. USA 87, 3861–3865.
Bever, C. T. Jr. and Garver, D. W. (1995) Increased cathepsin B activity in multiple sclerosis brain. J. Neurol. Sci. 131, 71–73.
Ihara, M., Tomimoto, H., Kinoshita, M., Oh, J., Noda, M., Wakita, H., et al. (2001) Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the micro-glia and vascular endothelium of white matter. J. Cereb. Blood Flow Metab. 21, 828–834.
Gottschall, P. E., Yu, X., and Bing, B. (1995) Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J. Neurosci. Res. 42, 335–342.
Yoshiyama, Y., Sato, H., Seiki, M., Shinagawa, A., Takahashi, M., and Yamada, T. (1998) Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues. Acta Neuropathol. (Berl.) 96, 347–350.
Yoshiyama, Y., Asahina, M., and Hattori, T. (2000) Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain. Acta Neuropathol. (Berl.) 99, 91–95.
Leake, A., Morris, C. M., and Whateley, J. (2000) Brain matrix metalloproteinase 1 levels are elevated in Alzheimer’s disease. Neurosci. Lett. 291, 201–203.
Schlomann, U., Rathke-Hartlieb, S., Yamamoto, S., Jockusch, H., and Bartsch, J. W. (2000) Tumor necrosis factor a induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration. J. Neurosci. 20, 7964–7971.
Nakajima, K., Tsuzaki, N., Takemoto, N., and Kohsaka, S. (1992) Production and secretion of plasminogen in cultured rat brain microglia. FEBS Lett. 308, 179–182.
Nakajima, K., Tsuzaki, N., Shimojo, M., Hamanoue, M., and Kohsaka, S. (1992) Micro-glia isolated from rat brain secrete a urokinase-type plasminogen activator. Brain Res. 577, 285–292.
Behrendt, N., Ronne, E., and Dane, K. (1993) Binding of the urokinase-type plasminogen activator to its cell surface receptor is inhibited by low doses of suramin. J. Biol. Chem. 268, 5985–5989.
Nakajima, K., Shimojo, M., Hamanoue, M., Ishiura, S., Sugita, H., and Kohsaka, S. (1992) Identification of elastase as a secretory protease from cultured rat microglia. J. Neurochem. 58, 1401–1408.
Matsuo, M., Hamasaki, Y., Fujiyama, F., and Miyazaki, S. (1995) Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures. Brain Res. 685, 201–204.
Minghetti, L. and Levi, G. (1995) Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J. Neurochem. 65, 2690–2698.
McGeer, P. L., Harada, N., Kimura, H., McGeer, E. G., and Schulzer, M. (1992) Prevalence of dementia amongst elderly Japanese with leprosy: apparent effect of chronic drug therapy. Dementia 3, 146–149.
Breitner, J. C. S., Welsh, K. A., Helms, M. J., Gaskell, P. C., Gau, B. A., Roses, A. D., et al. (1995) Delayed onset of Alzheimer’s disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16, 523–530.
McGeer, P. L. and Rogers, J. (1992) Anti-inflammatory agents as a therapeutic approach to Alzheimer’ s disease. Neurology 42, 447–449.
Hull, M., Lieb, K., and Fiebich, B. L. (2000) Anti-inflammatory drugs: a hope for Alzheimer’ s disease? [review]. Expert Opin. 9, 671–683.
Blain, H., Jouzeau, J.Y., Blain, A., Terlain, B., Trechot, P., Touchon, J., et al. (2000) Alzheimer’s disease and non steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2: rationale and perspectives. Presse Med. 29, 267–273 (in French).
Halliday, G. M., Shepherd, C. E., McCann, H., Reid, W. J., Grayson, D. A., Broe, G. A., et al. (2000) Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease. Arch. Neurol. 57, 831–836.
Hoozemans, J. M., Rozemuller, A. M., Janssen, I., De Groot, C. A., Veerhuis, R., Eikelenboom, P. (2001) Cyclooxygenase expression in microglia and neurons in Alzheimer’s disease and control brain. Acta Neuropathol. 101, 2–8.
Yermakova, A. V., Rollins, J., Callahan, L. M., Rogers, J., and O’Banion, M. K. (1999) Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons. J. Neuropathol. Exp. Neurol. 58, 1135–1146.
Woodroofe, M. N., Sarna, G. S., Wadhwa, M., Hayes, G. M., Loughlin, A. J., Tinker, A., et al. (1991) Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33, 227–236.
Bauer, J., Ganter, U., Strauss, S., Stadtmüller, G., Frommberger, U., Bauer, H., et al. (1992) The participation of interleukin-6 in the pathogenesis of Alzheimer’s disease. Res. Immunol. 143, 650–657.
Yan, H. Q., Banos, M. A., Herregodts, P., Hooghe, R., and Hooghe-Peters, E. L. (1992) Expression of interleukin (IL)-1(3, IL-6 and their respective receptors in the normal rat brain and after injury. Eur. J. Immunol. 22, 2963–2971.
Castrell, J. V., Andus, T., Kunz, D., and Heinrich, P. C. (1989) Interleukin-6: the major regulator of acute-phase protein synthesis in man and rat. Ann. NYAcad. Sci. 557, 87–101.
Wood, J. A., Wood, P. L., Ryan, R., Graff-Radford, N. R., Pilapil, C., Robitaille, Y., and Quirion, R. (1993) Cytokine indices in Alzheimer’s temporal cortex: no changes in mature IL-1 [3 or IL-1RA but increases in the associated acute phase proteins IL-6, a2-macroglobulin and C-reactive protein. Brain Res. 625, 245–252.
Shohami, E., Novikov, M., Bass, R., Yamin, A., and Gailly, R. (1994) Closed head injury triggers early production of TNFalpha and IL-6 by brain injury. J. Cereb. Blood Flow Metab. 14, 615–619.
Minami, M., Kuraishi, Y., and Satoh, M. (1991) Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNFalpha and LIF in the rat brain. Biochem. Biophys. Res. Cornmun. 176, 593–598.
Gillespie, J. S., Cavanagh, H. M. A., Behan, W. M. H., Morrison, L. J. A., McGarry, F., and Behan, P. O. (1993) Increased transcription of interleukin-6 in the brains of mice with chronic enterovirus infection. J. Gen. Virol. 74, 741–743.
McGeer, P. L. and McGeer, E. G. (1992) Complement proteins and complement inhibitors in Alzheimer’s disease. Res. Immunol. 143, 621–624.
Ishii, T. and Haga, S. (1992). Complements, microglial cells and amyloid fibril formation. Res. Immunol. 143, 614–616.
McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I., and McGeer, E. G. (1993) Microglia in degenerative neurological disease. Glia 7, 84–92.
Hofman, F. M., Hinton, D. R., Johnson, K., and Merrill, J. E. (1989) Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170, 607–612.
Walker, D. G. and McGeer, P. L. (1992) Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Mol. Brain Res. 14, 109–116.
Brachova, L., Lue, L, Schultz, J., el Rashidy, T., and Rogers, J. (1993) Association cortex, cerebellum, and serum concentrations of Clq and factor B in Alzheimer’s disease. Mol. Brain Res. 18, 329–334.
Walker, D. G., Kim, S. U., and McGeer, P. L. (1995) Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40, 478–493.
Walker, D. G., Yasuhara, O., Patston, P. A., McGeer, E. G., and McGeer, P. L. (1995) Complement Cl inhibitor is produced by brain tissue and is cleaved in Alzheimer disease. Brain Res. 675, 75–82.
Gordon, D. L., Sadlon, T. A., Wesselingh, S. L., Russell, S. M., Johnstone, R. W., and Purcell, D. F. J. (1992) Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation. J. Neuroimmunol. 36, 199–208.
McGeer, P. L., Walker, D. G., Akiyama, H., Kawamata, T., Guan, A. L., Parker, C. J., Okada, N., and McGeer, E. G. (1991) Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain. Brain Res. 544, 315–319.
Gordon, D. L., Sadlon, T., Hefford, C., and Adrian, D. (1993) Expression of CD50, a regulator of the membrane attack complex of complement, on human astrocytes. Mol. Brain Res. 18, 335–338.
McGeer, P. L., Kawamata, T., and Walker, D. G. (1992) Distribution of clusterin in Alzheimer brain tissue. Brain Res. 579, 337–341.
Bertrand, P., Poirier, J., Oda, T., Finch, C. E., and Pasinetti, G. M. (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Mol. Brain Res. 33, 174–178.
Akiyama, H., Kawamata, T., Dedhar, S., and McGeer, P. L. (1991) Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue. J. Neuroimmunol. 32, 19–28.
Sobel, R. A., Chen, M., Maeda, A., and Hinojoza, J. R. (1995) Vitronectin and integrin vitronectin receptor localization in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 54, 202–213.
Wisniewski, T. and Frangione, B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235–238.
Griffin, W. S. T., Sheng, J. G., Roberts, G. W., and Mrak, R. E. (1995) Interleukin-1 expression in different plaque types in Alzheimer’s disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54, 276–281.
McGeer, P. L., Akiyama, H., Kawamata, T., Yamada, T., Walker, D. G., and Ishii, T. (1992) Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy. J. Neurosci. Res. 31, 428–442.
Konig, G., Monning, U., Czech, C., Prior, R., Banatis, R., Schreiter-Gasser, U., et al. (1992) Identification and differential expression of a novel alternative splice isoform of the ßA4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J. Biol. Chem. 267, 10804–10809.
Töpper, R., Gehrmann, J., Banati, R., Schwarz, M., Block, F., Noth, J., et al. (1995) Rapid appearance of (3-amyloid precursor protein immunoreactivity in glial cells following excitotoxic brain injury. Acta Neuropathol. 89, 23–28.
Perlmutter, L. S., Barron, E., and Chui, H. C. (1990) Morphologic association between microglia and senile plaque amyloid in Alzheimer’s disease. Neurosci. Lett. 119, 32–36.
Frackowiak, J., Wisniewski, H. M., Wegiel, J., Merz, G. S., Iqbal, K., and Wang, K. L. (1992) Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce (3-amyloid fibrils. Acta Neuropathol. (Berl.) 84, 225–233.
Mackenzie, I. R. A., Hao, C. H., and Munoz, D. G. (1995) Role of microglia in senile plaque formation. Neurobiol. Aging 16, 797–804.
Araujo, D. M. and Cotman, C. W. (1992) (3-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer’s disease. Brain Res. 569, 141–145.
Aihara, N., Ishii, S., Kume, K., and Shimizu, T. (2000) Interaction between neurone and microglia mediated by platelet-activating factor. Genes Cells 5, 397–406.
Dijkstra, S., Geisert, E. E., Gispen, W. H., Bar, P. R., and Joosten, E. J. (2000) Up-regulation of CD81 (target of the antiproliferative antibody; TAPA) by reactive micro-glia and astrocytes after spinal cord injury in the rat. J. Comp. Neurol. 428, 266–277.
Frigerio, S., Silei, V., Ciusani, E., Massa, G., Lauro, G. M., and Salmaggi, A. (2000) Modulation of Fas-Ligand (Fas-L) on human microglial cells: an in vitro study. J. Neuroimmunol. 105, 109–114.
Boje, K. M. and Arora, P. K. (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587, 250–256.
Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., and Peterson, P. K. (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736–2741.
Colton, C. A. and Gilbert, D. L. (1993) Microglia, an in vivo source of reactive oxygen species in the brain. Adv. Neurol. 59, 321–326.
Wood, P. L., Choksi, S., and Bocchini, V. (1994) Inducible microglial nitric oxide synthase: a large membrane pool. Neuroreport 5, 977–980.
Chao; C. C., Hu, S., Close, K., Choi, C. S., Molitor, T. W., Novick, W. J., et al. (1992) Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J. Infect. Dis. 166, 847–853.
Peterson, P. K., Hu, S., Anderson, W. R., and Chao, C. C. (1994) Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J. Infect. Dis. 170, 457–460.
Bö, L., Dawson, T. M., Wesselingh, S., Mörk, S., Choi, S., Kong, P. A., et al. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778–786.
Walker, D. G., Kim, S. U., and McGeer, P. L. (1995) Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40, 478–493.
Sherman, M. P., Griscavage, J. M., and Ignarro, L. J. (1992) Nitric oxide-mediated neuronal injury in multiple sclerosis. Med. Hypotheses 39, 143–146.
Colasanti, M., Persichini, T., Di Pucchio, T., Gremo, F., and Lauro, G. M. (1995) Human ramified microglial cells produce nitric oxide upon Escherichia coli lipopolysaccharide and tumor necrosis factor a stimulation. Neurosci. Lett. 200, 144–146.
Bagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V., Fu, Z. F., et al. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 92, 12041–12045.
Kontes, H. K. and Wei, E. P. (1986) Superoxide production in experimental brain injury. J. Neurosurg. 64, 803–807.
Colton, C. A., Yao, J., Gilbert, D., and Oster-Granite, M. L. (1990) Enhanced production of superoxide anion by microglia from trisomy 16 mice. Brain Res. 519, 236–242.
Zhou, Y., Richardson, J. S., Mombourquette, M. J., and Weil, J. A. (1995) Free radical formation in autopsy samples of Alzheimer and control cortex. Neurosci. Lett. 195, 89–92.
Schwab, J. M., Brechtel, K., Nguyen, T. D., and Schluesener, H. J. (2000) Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury. J. Neuroimmunol. 111, 122–130.
Schwab, J. M., Nguyen, T. D., Postler, E., Meyermann, R., and Schluesener, H. J. (2000) Selective accumulation of cyclooxygenase-l-expressing microglial cells/macrophages in lesions of human focal cerebral ischemia. Acta Neuropathol. 99, 609–614.
Advances in Alzheimer Therapy. Sixth International Stockholm/Springfield Symposium, 2000.
Wood, P. L. (1998) Disease-modifying drugs for Alzheimer’s disease?: inhibitors of apoptosis, APP processing and prostaglandin formation. IDrugs 1, 675–677.
Hadland, B. K., Manley, N. R., Su, D. M., Longmore, G. D., Moore, C. L., Wolfe, M. S., et al. (2001) Gamma-secretase inhibitors repress thymocyte development. Proc. Natl. Acad. Sci. USA 98, 7487–7491.
Brayden, D. J., Templeton, L., McClean, S., Barbour, R., Huang, J. P., Nguyen, M., et al. (2001) Encapsulation in biodegradable microparticles enhances serum antibody response to parenterally-delivered beta-amyloid in mice. Vaccine 19, 4185–4193.
Akama, K. T. and Van Eldik, L. J. (2000) 13-Amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1 beta-and tumor necrosis factor-alpha (TNF alpha)-dependent, and involves a TNF alpha receptor-associated factor-and NF kappa B-inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275, 7918–7924.
Justicia, C., Gabriel, C., and Planas, A. M. (2000) Activation of the JAK/STAT pathway following transient focal cerebral ischemia: signaling through Jakl and Stat3 in astrocytes. Glia 30, 253–270.
Tan, J., Town, T., and Mullan, M. (2000) CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J. Biol. Chem. 275, 37224–37231.
Tan, J., Town, T., Mori, T., Wu, Y. J., Saxe, M., Crawford, F., et al. (2000) CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J. Neurosci. 20, 7587–7594.
Hasegawa, H., Nakai, M., Tanimukai, S., Taniguchi, T., Terashima, A., Kawamata, T., et al. (2001) Microglial signaling by amyloid beta protein through mitogen-activated protein kinase mediating phosphorylation of MARCKS. Neuroreport 12, 2567–2571.
Fabrizi, C., Silei, V., Menegazzi, M., Salmona, M., Bugiani, O., Tagliavini, F., et al. (2001) The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106–126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase. J. Biol. Chem. 276, 25692–25696.
Ryu, J., Pyo, H., Jou, I., and Joe, E. H. (2000) Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B. J. Biol. Chem. 275, 29955–29959.
Schlapbach, R., Spanaus, K. S., Malipiero, U., Lens, S., Tasinato, A., Tschopp, J., et al. (2000) TGF-beta induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia. Eur. J. Immunol. 30, 3680–3688.
Lee, Y. B., Schrader, J. W., and Kim, S. U. (2000) p38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. Cytokine 12, 874–880.
Hide, I., Tanaka, M., Inoue, A., Nakajima, K., Kohsaka, S., Inoue, K., et al. (2000) Extra-cellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J. Neurochem. 75, 965–972.
Zhu, X. W., Rottkamp, C. A., Boux, H., Takeda, A., Perry, G., and Smith, M. A. (2000) Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59, 880–888.
Zhu, X., Rottkamp, C. A., Hartzler, A., Sun, Z., Takeda, A., Boux, H., et al. (2001) Activation of MKK6, an upstream activator of p38, in Alzheimer’s disease. J. Neurochem. 79, 311–318.
Hensley, K., Floyd, R. A., Zheng, N. Y., Nael, R., Robinson, K. A., Nguyen, X., et al. (1999) p38 kinase is activated in the Alzheimer’s disease brain. J. Neurochem. 72, 2053–2058.
Monnet-Tschudi, F., Zurich, M. G., Pithon, E., Van Melle, G., and Honegger, P. (1995) Microglial responsiveness as a sensitive marker for trimethyltin (TMT) neurotoxicity. Brain Res. 690, 8–14.
McCann, M. J., O’Callaghan, J. P., Martin, P. M., Bertram, T., and Streit, W. J. (1996) Differential activation of microglia and astrocytes following trimethyl tin-induced neuro-degeneration. Neuroscience 72, 273–281.
Maier, W. E., Brown, H. W., Tilson, H. A., Luster, M. I., and Harry, G. J. (1995) Trimethyltin increases interleukin (IL)-1a, IL-6 and tumor necrosis factor a mRNA levels in rat hippocampus. J. Neuroimmunol. 59, 65–75.
Mogi, M., Togari, A., Tanaka, K., Ogawa, N., Ichinose, H., and Nagatsu, T. (2000) Increase in level of tumor necrosis factor-alpha in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506. Neurosci. Lett. 289, 165–168.
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinanen, R., and Koistinaho, J. (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21, 2580–2588.
Hensley, K., Robinson, K. A., Pye, Q. N., Floyd, R. A., Cheng, I., Garland, W. A., et al. (2000) CPI-1189 inhibits interleukin lbeta-induced p38-mitogen-activated protein kinase phosphorylation: an explanation for its neuroprotective properties? Neurosci. Lett. 281, 179–182.
Pulliam, L., Irwin, I., Kusdra, L., Rempel, H., Flitter, W. D., and Garland, W. A. (2001) CPI-1189 attenuates effects of suspected neurotoxins associated with AIDS dementia: a possible role for ERK activation. Brain Res. 893, 95–103.
Bjugstad, K. B., Flitter, W. D., Garland, W. A., Su, G. C., and Arendash, G. W. (1998) Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia. Brain Res. 795, 349–357.
Bjugstad, K. B., Flitter, W. D., Garland, W. A., Philpot, R. M., Kirstein, C. L., and Arendash, G. W. (2000) CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex. J. Neurovirol. 6, 478–491.
Lim, G. P., Chu, T., Yang, F. S., Beech, W., Frautschy, S. A., and Cole, G. M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 8370–8377.
Wood, P. L. (1994) Microglia: a possible cellular target for pharmacological approaches to neurodegenerative disorders. Drug News Perspect. 7, 138–157.
Lee, Y. B., Schrader, J. W., and Kim, S. U. (2000) p38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. Cytokine 12, 874–880.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Wood, P.L. (2003). Microglia. In: Wood, P.L. (eds) Neuroinflammation. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-297-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-59259-297-5_1
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9720-5
Online ISBN: 978-1-59259-297-5
eBook Packages: Springer Book Archive